MacroGenics
MGNX
#9393
Rank
โ‚น7.78 B
Marketcap
โ‚น123.08
Share price
-0.72%
Change (1 day)
-57.13%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น13.15 Billion

According to MacroGenics's latest financial reports the company has โ‚น13.15 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น17.30 B-9.57%
2023-12-31โ‚น19.13 B49.79%
2022-12-31โ‚น12.77 B-29.56%
2021-12-31โ‚น18.13 B-9.02%
2020-12-31โ‚น19.93 B29.54%
2019-12-31โ‚น15.38 B-5.51%
2018-12-31โ‚น16.28 B-16.42%
2017-12-31โ‚น19.48 B3.5%
2016-12-31โ‚น18.82 B-16.46%
2015-12-31โ‚น22.53 B125.59%
2014-12-31โ‚น9.98 B38.79%
2013-12-31โ‚น7.19 B175.29%
2012-12-31โ‚น2.61 B-10.51%
2011-12-31โ‚น2.92 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Xencor
XNCR
โ‚น42.31 B 221.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.346 T 10,135.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 12,341.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น660.20 B 4,919.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น848.50 B 6,351.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น890.59 B 6,671.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 11,172.09%๐Ÿ‡บ๐Ÿ‡ธ USA